Transfish: The multiple origins of transgenic salmon

Other Publication ResearchOnline@JCU
Stevens, Hallam
Hallam Stevens
Abstract

AquAdvantage salmon was approved for human consumption by the US Food and Drug Administration (FDA) in 2015 after a 20-year process. The fish – with inserted genes promoting rapid growth and disease resistance – was the first transgenic animal designed for eating. This chapter examines the various ways in which risk around AquAdvantage salmon was framed and managed by the various parties involved. It argues that a key (and ultimately successful) strategy was the geographic displacement of risk to scientific and global “peripheries.”

Journal

N/A

Publication Name

Synthetic Biology 2020: Frontiers in risk analysis and governance

Volume

N/A

ISBN/ISSN

978-3-030-27264-7

Edition

N/A

Issue

N/A

Pages Count

13

Location

N/A

Publisher

Springer

Publisher Url

N/A

Publisher Location

Cham, Switzerland

Publish Date

N/A

Url

N/A

Date

N/A

EISSN

N/A

DOI

10.1007/978-3-030-27264-7_3